markus hecht
Faculty of Medicine, University of Erlangen Nuremberg
Erlangen, Germany
Review Editor
Cancer Immunity and Immunotherapy
Faculty of Medicine, University of Erlangen Nuremberg
Erlangen, Germany
Review Editor
Cancer Immunity and Immunotherapy
Mayo Clinic
Rochester, United States
Review Editor
Cancer Immunity and Immunotherapy
Baylor College of Medicine
Houston, United States
Review Editor
Cancer Immunity and Immunotherapy
Cancer Institute, Erasmus Medical Center
Rotterdam, Netherlands
Review Editor
Cancer Immunity and Immunotherapy
University Hospital and Faculty of Medicine, University of Tübingen
Tübingen, Germany
Review Editor
Cancer Immunity and Immunotherapy
Departamento de Ciencias Básicas, Facultad de Medicina, Universidad Católica de la Santísima Concepción
Concepción, Chile
Review Editor
Cancer Immunity and Immunotherapy
University Hospital Erlangen
Erlangen, Germany
Review Editor
Cancer Immunity and Immunotherapy
Malaghan Institute of Medical Research, Faculty of Science, Victoria University of Wellington
Wellington, New Zealand
Review Editor
Cancer Immunity and Immunotherapy
Institute of Molecular and Cellular Biology of Cancer, Spanish National Research Council (CSIC)
Salamanca, Spain
Review Editor
Cancer Immunity and Immunotherapy
Hospital Reina Sofía de Córdoba
Cordova, Spain
Review Editor
Cancer Immunity and Immunotherapy
Osaka University
Suita, Japan
Review Editor
Cancer Immunity and Immunotherapy
QIMR Berghofer Medical Research Institute, The University of Queensland
Herston, Australia
Review Editor
Cancer Immunity and Immunotherapy
Dana–Farber Cancer Institute
Boston, United States
Review Editor
Cancer Immunity and Immunotherapy
Monash University
Melbourne, Australia
Review Editor
Cancer Immunity and Immunotherapy
University of Florida
Gainesville, United States
Review Editor
Cancer Immunity and Immunotherapy
University of California, Los Angeles
Los Angeles, United States
Review Editor
Cancer Immunity and Immunotherapy